Donor Cell-derived Osteopoiesis Originates from a Self-renewing Stem Cell with a Limited Regenerative Contribution After Transplantation

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2008 Jan 10

PMID 18182575

Citations 25

Authors

Massimo Dominici

Roberta Marino

Valeria Rasini

Carlotta Spano

Paolo Paolucci

Pierfranco Conte

Ted J Hofmann

Edwin M Horwitz

Affiliations

Soon will be listed here.

Abstract

In principle, bone marrow transplantation should offer effective treatment for disorders originating from defects in mesenchymal stem cells. Results with the bone disease osteogenesis imperfecta support this hypothesis, although the rate of clinical improvement seen early after transplantation does not persist long term, raising questions as to the regenerative capacity of the donor-derived mesenchymal progenitors. We therefore studied the kinetics and histologic/anatomic pattern of osteopoietic engraftment after transplantation of GFP-expressing nonadherent marrow cells in mice. Serial tracking of donor-derived GFP(+) cells over 52 weeks showed abundant clusters of donor-derived osteoblasts/osteocytes in the epiphysis and metaphysis but not the diaphysis, a distribution that paralleled the sites of initial hematopoietic engraftment. Osteopoietic chimerism decreased from approximately 30% to 10% by 24 weeks after transplantation, declining to negligible levels thereafter. Secondary transplantation studies provided evidence for a self-renewing osteopoietic stem cell in the marrow graft. We conclude that a transplantable, primitive, self-renewing osteopoietic cell within the nonadherent marrow cell population engrafts in an endosteal niche, like hematopoietic stem cells, and regenerates a significant fraction of all bone cells. The lack of durable donor-derived osteopoiesis may reflect an intrinsic genetic program or exogenous environmental signaling that suppresses the differentiation capacity of the donor stem cells.

Citing Articles

Enzyme-Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells.

Kawai H, Oo M, Takabatake K, Tosa I, Soe Y, Eain H JBMR Plus. 2023; 7(3):e10722.

PMID: 36936364 PMC: 10020919. DOI: 10.1002/jbm4.10722.

Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing.

Nita M, Pliszczynski J, Kosieradzki M, Fiedor P Dermatol Ther (Heidelb). 2021; 11(5):1469-1480.

PMID: 34269966 PMC: 8484405. DOI: 10.1007/s13555-021-00578-w.

Clinical Application of Bone Marrow Mesenchymal Stem/Stromal Cells to Repair Skeletal Tissue.

Arthur A, Gronthos S Int J Mol Sci. 2020; 21(24).

PMID: 33371306 PMC: 7767389. DOI: 10.3390/ijms21249759.

The Role of Bone Marrow-Derived Cells during Ectopic Bone Formation of Mouse Femoral Muscle in GFP Mouse Bone Marrow Transplantation Model.

Takabatake K, Tsujigiwa H, Song Y, Matsuda H, Kawai H, Fujii M Int J Med Sci. 2018; 15(8):748-757.

PMID: 30008583 PMC: 6036083. DOI: 10.7150/ijms.24605.

Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells.

Brooks A, Futrega K, Liang X, Hu X, Liu X, Crawford D Stem Cells Transl Med. 2017; 7(1):78-86.

PMID: 29210198 PMC: 5746161. DOI: 10.1002/sctm.17-0209.

References

Calvi L, Sims N, Hunzelman J, Knight M, Giovannetti A, Saxton J . Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest. 2001; 107(3):277-86. PMC: 199196. DOI: 10.1172/JCI11296. View

Horwitz E, Prockop D, Gordon P, Koo W, Fitzpatrick L, Neel M . Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood. 2001; 97(5):1227-31. DOI: 10.1182/blood.v97.5.1227. View

Gao J, Dennis J, Muzic R, Lundberg M, Caplan A . The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001; 169(1):12-20. DOI: 10.1159/000047856. View

Hauge E, Qvesel D, Eriksen E, Mosekilde L, Melsen F . Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res. 2001; 16(9):1575-82. DOI: 10.1359/jbmr.2001.16.9.1575. View

Horwitz E, Gordon P, Koo W, Marx J, Neel M, McNall R . Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A. 2002; 99(13):8932-7. PMC: 124401. DOI: 10.1073/pnas.132252399. View

Askenasy N, Zorina T, Farkas D, Shalit I . Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivo. Stem Cells. 2002; 20(4):301-10. DOI: 10.1634/stemcells.20-4-301. View

Ichioka N, Inaba M, Kushida T, Esumi T, Takahara K, Inaba K . Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells. 2002; 20(6):542-51. DOI: 10.1634/stemcells.20-6-542. View

Whyte M, Kurtzberg J, McAlister W, Mumm S, Podgornik M, Coburn S . Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res. 2003; 18(4):624-36. DOI: 10.1359/jbmr.2003.18.4.624. View

Brazelton T, Nystrom M, Blau H . Significant differences among skeletal muscles in the incorporation of bone marrow-derived cells. Dev Biol. 2003; 262(1):64-74. DOI: 10.1016/s0012-1606(03)00357-9. View

10.

Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View

11.

Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

12.

Corbel S, Lee A, Yi L, Duenas J, Brazelton T, Blau H . Contribution of hematopoietic stem cells to skeletal muscle. Nat Med. 2003; 9(12):1528-32. DOI: 10.1038/nm959. View

13.

Camargo F, Green R, Capetanaki Y, Jackson K, Goodell M, Capetenaki Y . Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med. 2003; 9(12):1520-7. DOI: 10.1038/nm963. View

14.

Olmsted-Davis E, Gugala Z, Camargo F, Gannon F, Jackson K, Kienstra K . Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A. 2003; 100(26):15877-82. PMC: 307661. DOI: 10.1073/pnas.2632959100. View

15.

Dominici M, Pritchard C, Garlits J, Hofmann T, Persons D, Horwitz E . Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A. 2004; 101(32):11761-6. PMC: 511049. DOI: 10.1073/pnas.0404626101. View

16.

McCulloch C, Heersche J . Lifetime of the osteoblast in mouse periodontium. Anat Rec. 1988; 222(2):128-35. DOI: 10.1002/ar.1092220204. View

17.

Pereira R, Halford K, OHara M, Leeper D, Sokolov B, Pollard M . Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995; 92(11):4857-61. PMC: 41806. DOI: 10.1073/pnas.92.11.4857. View

18.

Persons D, Allay J, Allay E, Smeyne R, Ashmun R, Sorrentino B . Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood. 1997; 90(5):1777-86. View

19.

Onyia J, Clapp D, Long H, Hock J . Osteoprogenitor cells as targets for ex vivo gene transfer. J Bone Miner Res. 1998; 13(1):20-30. DOI: 10.1359/jbmr.1998.13.1.20. View

20.

Pereira R, OHara M, Laptev A, Halford K, Pollard M, Class R . Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A. 1998; 95(3):1142-7. PMC: 18700. DOI: 10.1073/pnas.95.3.1142. View